摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-nitroamino-5-(2-methoxy-pyridin-4-yl)methyl-4-pyrimidone | 72716-89-3

中文名称
——
中文别名
——
英文名称
2-nitroamino-5-(2-methoxy-pyridin-4-yl)methyl-4-pyrimidone
英文别名
2-nitroamino-5-(2-methoxypyrid-4-ylmethyl)-4-pyrimidone;2-nitroamino-5-(2-methoxy-pyridin-4-ylmethyl)-4-pyrimidone;2-nitroamino-5-(2-methoxy-4-pyridyl)methyl-4-pyrimidone;2-nitroamino-5-(2-methoxy-4-pyridylmethyl)-4-pyrimidone;N-[5-[(2-methoxypyridin-4-yl)methyl]-6-oxo-1H-pyrimidin-2-yl]nitramide
2-nitroamino-5-(2-methoxy-pyridin-4-yl)methyl-4-pyrimidone化学式
CAS
72716-89-3
化学式
C11H11N5O4
mdl
——
分子量
277.239
InChiKey
DYSDJZQYNYDJBU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    194-195.5 °C
  • 密度:
    1.54±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    121
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-nitroamino-5-(2-methoxy-pyridin-4-yl)methyl-4-pyrimidone盐酸 作用下, 以 乙醇 为溶剂, 反应 24.0h, 生成
    参考文献:
    名称:
    Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds
    摘要:
    The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.
    DOI:
    10.1016/0223-5234(93)90091-r
  • 作为产物:
    描述:
    4-氰基-2-甲氧基吡啶 在 palladium on activated charcoal 、 哌啶吡啶盐酸聚合甲醛氢气sodium methylate盐酸氨基脲sodium acetate 、 sodium hydride 作用下, 以 甲醇乙二醇二甲醚乙醇 为溶剂, 反应 38.5h, 生成 2-nitroamino-5-(2-methoxy-pyridin-4-yl)methyl-4-pyrimidone
    参考文献:
    名称:
    Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds
    摘要:
    The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.
    DOI:
    10.1016/0223-5234(93)90091-r
点击查看最新优质反应信息

文献信息

  • Intermediates in the process for making histamine antagonists
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04227000A1
    公开(公告)日:1980-10-07
    A process for making substituted 2-aminopyrimidones which are histamine H.sub.2 - antagonists which comprises reacting a 2-nitroaminopyrimidone with a heteroarylalkylamine, heteroarylalkylthioalkylamine, or heteroarylalkoxyalkylamine. One particular compound which can be made by this process is 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-[5-(1,3-benzodioxolyl) methyl]-4-pyrimidone. Also claimed are 2-nitroaminopyrimidone intermediates for use in this process. One specific intermediate is 2-nitroamino-5-[5-(1,3-benzodioxolyl)methyl]-4-pyrimidone.
    一种制备取代2-氨基嘧啶酮的方法,这些化合物是组胺H.sub.2-拮抗剂,包括将2-硝基氨基嘧啶酮与杂环烷基胺、杂环烷基硫代烷基胺或杂环烷基氧代烷基胺反应。通过这种方法可以制备一种特定化合物,即2-[2-(5-甲基-4-咪唑基甲硫基)乙基氨基]-5-[5-(1,3-苯并二氧杂环己基)甲基]-4-嘧啶酮。此外,还声明了用于该方法的2-硝基氨基嘧啶酮中间体。其中一个特定的中间体是2-硝基氨基-5-[5-(1,3-苯并二氧杂环己基)甲基]-4-嘧啶酮。
  • Pyrimidone derivatives
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04385058A1
    公开(公告)日:1983-05-24
    This invention relates to 2-amino-4-pyrimidone derivatives, in which the amino group is substituted by a methylthioethyl, butyl or oxypropyl group bearing a terminal 4-dialkylaminomethyl-2-pyridyl group. The compounds have histamine H.sub.2 -antagonist activity. A specific compound of this invention is 2-[2-(4-dimethylaminomethyl-2-pyridylmethylthio)ethylamino]-5-(6-methyl-3- pyridylmethyl)-4-pyrimidone.
    这项发明涉及2-氨基-4-嘧啶酮衍生物,其中氨基团被甲硫乙基、丁基或氧丙基取代,带有一个末端的4-二烷基氨甲基-2-吡啶基团。这些化合物具有组胺H.sub.2-拮抗活性。该发明的一个具体化合物是2-[2-(4-二甲基氨甲基-2-吡啶基硫代)乙基氨基]-5-(6-甲基-3-吡啶基甲基)-4-嘧啶酮。
  • 5-(Hydroxypyridylalkyl)-4-pyrimidones
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04255428A1
    公开(公告)日:1981-03-10
    The compounds are substituted 2-amino-4-pyrimidones with a 5-(hydroxypyridylalkyl) substituent which are histamine H.sub.2 -antagonists. Two specific compounds are 2-[2-(3-bromo-2-pyridylmethylthio)ethylamino]-5-(2-hydroxy-4-pyridylmethyl )-4-pyrimidone and 2-[4-(3-methoxy-2-pyridyl)butylamino]-5-(2-hydroxy-4-pyridylmethyl)-4-pyri midone.
    这些化合物是具有5-(羟基吡啶基)取代基的2-氨基-4-嘧啶酮,是组胺H.sub.2-拮抗剂。两种特定的化合物是2-[2-(3-溴-2-吡啶甲硫基)乙基氨基]-5-(2-羟基-4-吡啶甲基)-4-嘧啶酮和2-[4-(3-甲氧基-2-吡啶基)丁基氨基]-5-(2-羟基-4-吡啶甲基)-4-嘧啶酮。
  • Pyrimidine compounds
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04234588A1
    公开(公告)日:1980-11-18
    The compounds are substituted pyrimidine compounds which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-(5-dimethylaminomethyl)-2-furylmethylthio)ethylamino]-5-(3-pyridylmet hyl)-4-pyrimidone.
    这些化合物是被取代的嘧啶化合物,它们是组胺H.sub.2-拮抗剂。本发明的一种特定化合物是2-[2-(5-二甲胺甲基)-2-呋喃甲硫基)乙基氨基]-5-(3-吡啶甲基)-4-嘧啶酮。
  • Pyridines
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04439609A1
    公开(公告)日:1984-03-27
    This invention relates to 4-substituted aminomethyl pyridines with a butanamine, oxypropioamine or thiomethylamine substituent at the 2 position. The compounds are reacted with pyridones to form compounds which have histamine H.sub.2 -antagonist activity.
    本发明涉及在2位具有丁胺基、氧丙胺基或硫甲基取代基的4-取代氨基甲基吡啶中。这些化合物与吡啶酮反应形成具有组胺H.sub.2 -拮抗活性的化合物。
查看更多